Catalogo dei prodotti della ricerca

D'ERAMO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.522
EU - Europa 1.648
AS - Asia 1.144
AF - Africa 124
SA - Sud America 26
OC - Oceania 6
Totale 6.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.463
IT - Italia 837
IN - India 418
SG - Singapore 359
CN - Cina 326
FI - Finlandia 245
UA - Ucraina 165
SE - Svezia 146
TG - Togo 107
DE - Germania 67
CA - Canada 46
IE - Irlanda 46
GB - Regno Unito 32
NL - Olanda 22
AR - Argentina 17
FR - Francia 17
AT - Austria 16
KR - Corea 16
BE - Belgio 14
CH - Svizzera 11
MX - Messico 10
IR - Iran 6
RU - Federazione Russa 6
SC - Seychelles 6
ZA - Sudafrica 6
PT - Portogallo 5
AU - Australia 4
BG - Bulgaria 4
BR - Brasile 4
CL - Cile 4
EG - Egitto 4
HK - Hong Kong 4
ID - Indonesia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DO - Repubblica Dominicana 3
PL - Polonia 3
GR - Grecia 2
HR - Croazia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RO - Romania 2
TR - Turchia 2
VN - Vietnam 2
AD - Andorra 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
ES - Italia 1
MY - Malesia 1
Totale 6.470
Salva come PNG Salva come JPEG
Città #
Chandler 386
Fairfield 344
Princeton 276
Plano 233
Singapore 205
Woodbridge 176
Wilmington 170
Ashburn 164
Rome 136
Ann Arbor 131
Beijing 128
Houston 114
Lomé 107
Seattle 107
Cambridge 101
Boston 98
Millbury 85
Andover 66
Des Moines 63
San Diego 59
Jacksonville 57
San Paolo di Civitate 49
Milan 47
Dublin 46
Norwalk 40
Lawrence 35
Dearborn 33
Toronto 32
Nanjing 28
Santa Clara 28
Kunming 27
San Mateo 27
Bühl 24
Hefei 23
Guangzhou 19
New York 17
Amsterdam 16
Federal 16
Boardman 15
Nanchang 15
Vienna 15
Helsinki 14
Redmond 14
Dallas 12
Brussels 11
Udine 11
Chengdu 10
Falkenstein 10
Falls Church 10
Grafing 10
Jinan 10
Brescia 9
Redwood City 9
Venice 9
Buffalo 8
London 8
Salerno 8
Shaoxing 8
Trieste 8
Fuzhou 7
Ladispoli 7
Marano Di Napoli 7
Ottawa 7
Perugia 7
Seocho-gu 7
Torino 7
Mannheim 6
Oderzo 6
Shenyang 6
Turin 6
Fremont 5
Lisbon 5
Los Angeles 5
Mexico City 5
Albenga 4
Baotou 4
Bologna 4
Bremen 4
Bussolengo 4
Cairo 4
Canegrate 4
Como 4
Figline Valdarno 4
Genova 4
Grammichele 4
Hong Kong 4
Jesi 4
Muizenberg 4
Naples 4
Sofia 4
Staunton 4
Viterbo 4
Bari 3
Bern 3
Castelnuovo Rangone 3
Catania 3
Chaoyang 3
Dubai 3
Florence 3
Gangnam-gu 3
Totale 4.126
Salva come PNG Salva come JPEG
Nome #
Tumore del testicolo a cellule germinali "burned out" 523
Effects of long-term treatment with the anti-androgen bicalutamide on human testis: An ultrastructural and morphometric study 124
Impiego della lefetamina cloridrato (Santenol) nella piccola chirurgia urologica 115
Multidisciplinary team in cancer management 98
MRI-targeted or standard biopsy for prostate-cancer diagnosis 89
Advanced prostatic cancer: Clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate 78
Loss of Renal Function After Retrograde Ureteral Placement of an Allium Stent for Severe Ureteral Stricture 74
LESIONI PRECANCEROSE E GRAY ZONE: ASPETTI CLINICI E PATTERN RM 70
DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy 69
Effects of long term treatment with serenoa repens on the concentrations and regional distribution of androgen and epidermal growth factor in benign prostatic hyperplasia 68
Gleason score ≥ 8 prostate adenocarcinoma is associated with higher serum chromogranin A levels also in non metastatic disease. 67
ANDROGENIC AND ANTIANDROGENIC CONTROL ON EPIDERMAL GROWTH-FACTOR, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND ANDROGEN RECEPTOR EXPRESSION IN HUMAN PROSTATE-CANCER CELL-LINE LNCAP 67
EVIDENCE THAT SERENOA-REPENS EXTRACT DISPLAYS AN ANTIESTROGENIC ACTIVITY IN PROSTATIC TISSUE OF BENIGN PROSTATIC HYPERTROPHY PATIENTS 67
Age-adjusted mortality rate and regional distribution for human renal cell carcinoma in Italy between 1969 and 1978. 65
Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate 63
PENILE METASTASIS FROM CARCINOMA OF THE PROSTATE IN A PATIENT WITH HIGH SERUM PSA LEVELS 62
RELATIONSHIP AMONG SYMPTOMS SCORE,PROSTATE VOLUME AND URINARY FLOW RATES IN 543 PATIENTS WITH AND WIHTOUT BPH 60
RELATIONSHIP AMONG AGE, PSA AND PROSTATE VOLUME IN MEN WITH LUTS AND IN DIFFERENT GROUPS OF MEN WITH AND WIHTOUT BENIGN AND MALIGNANT PROSTATE DISEASES 58
Alternative forms of medical treatment in benign prostatic hyperplasia 57
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue 53
Cryotherapy for prostate cancer 53
L’immagine e l’anatomia patologica:il significato dell’atrofia ghiandolare focale nei pazienti con carcinoma prostatico. 51
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: A multicenter Italian study 50
Evidence that serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. 50
NEW ULTRASENSITIVE ASSAY DEVELOPMENT BY USING MONOCLONAL-ANTIBODIES FOR DETECTING PROSTATE-SPECIFIC ANTIGEN 49
The prognostic value of DNA content in patients with prostatic carcinoma. 49
A biochemical mediator of stromal-epithelial interaction:Epidermal Growth Factor levels and stromal epithelial content in different regions of human Benign Prostatic Hyperplasia tissue 48
New ultrasensitive assay development by using monoclonal antibodies for detecting prostate specific antigen 46
The prognostic value of DNA content in patients with prostatic carcinoma. 46
C and D1 prostate cancer. 45
Il citoaspirato e la biopsia istologica nella diagnosi del carcinoma prostatico. 45
Ecografia e citologia urinaria nella diagnosi dei tumori superficiali della vescica. 44
Anti estrogens and antiandrogens in human benign prostatic hyperplasia 44
Alcuni aspetti di fisiopatologia endocrina della iperplasia prostatica (IP) umana 44
Incidental prostatic carcinoma: Four-year follow-up after treatment with cyproterone acetate 43
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive role of serum chromogranin A. 43
Effect of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia 43
Affidabilità dell’ecotomografia nel follow-up delle neoplasie vescicali 40
Pathology of BPH. 39
Effects of long-term treatment with the anti-androgen bicalutamide on human testis: an ultrastructural and morphometric study 39
Biochemical and molecular assessment of epidermal growth factor and its receptor in LNCaP cell line following androgen and antiandrogen treatment 38
Biochemical mediator of stromal-epithelial interaction: Epithelial growth factor levels and stromal epithelial content in different regions of benign prostatic hypertrophy tissue 38
Acinar atrophy and prostatic intraepithelial neoplasia in prostate specimen from radical prostatectomy. 38
PHARMACOLOGICAL COMBINATIONS IN THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY 37
Biochemical and molecular assessment of epidermal growth factor and its receptor in LNCaP cell line following androgen and antiandrogen treatment 36
Effects of long-term treatment with antiandrogen Casodex on human testis. An ultrastructural and morphometric study. 36
A rare case of single metastatis of papillary carcinoma of the excretory tract treated with surgical therapy only 35
Oral ethinylestradiol in castration resistent prostate cancer: 10 year experience 35
Neoplasia transizionale infiltrante dell'uretra e dei dotti prostatici- uretrocistoprostato-vesciculectomia in blocco 35
Which patients with prostate cancer are actually candidates for hormone therapy? 35
Evaluation of causes of obstructive uropathy by MR pyelography 34
Approccio farmacologico all’ipertrofia prostatica benigna:razionale dell’utilizzo degli alfa1 bloccanti nell’esperienza clinica. 34
Androgenic and antiandrogenic control on prostate cancer progression: response to intermittent androgen deprivation (IAD) 34
Response of tissue androgen and epidermal growth factor concentrations to the administration of finasteride, flutamide and serenoa repens in patients with benign prostatic hyperplasia 33
Carcinoma a cellule renali associato co altri tumori primitivi in organi bersaglio di ormoni steroidei .Influenza della storia riproduttiva e dei fattori ormonali 33
Correlation between serum PSA and intraprostatic concentration of EGF and DHT in patients with BPH 33
MR pyelography in the evaluation of causes of obstructive uropathy. 32
A rare case of association of polycystic kidney and hypernephroma 32
La fisiopatologia dello stravaso urinoso nella ostruzione acuta della via escretrice 32
Multidisciplinary team (MDT) in cancer management. 32
Gleason score >/=8 prostate adenocarcinoma is associated with higher serum cromogranin A levels also in non metastatic disease. 31
High insuline-growth factor I and II and type 1 receptor expression in the periurethral region o human prostatic hyplerplasia tissue 31
Biochemical and molecular assessment of epidermal growth factor and its receptor in LNCaP cell line following androgen and antiandrogen treatment 31
Corrispondenza tra interessamento dei margini chirurgici in corso di prostatectomia radicale evidenziati con ecografia ad “immersione” e curva di discesa del Psa. 31
PSA as a prognostic factor in prostate cancer. 31
Terapia con Flutamide nei pazienti con carcinoma prostatico in stadio avanzato. 31
High insuline-growth factor I and II and type 1 receptor expression in the periurethral region o human prostatic hyplerplasia tissue. 30
Segni clinici, stadiazione, randomizzazione e sopravvivenza in 105 pazienti con adenocarcinoma renale. 30
Metastasi orbitaria da carcinoma prostatico: valutazione della risposta alla terapia ormonosoppressiva 29
The “dipping” sonography for the evaluation of the surgical margins during radical prostatectomy of patients with intracapsular prostatic cancer. 29
Role of prostate specific antigen and its "derivatives" (age-referenced PSA, PSA density, PSA velocity, free/total PSA) in the diagnosis and evaluation of prostate cancer [Ruolo dell'antigene prostatico specifico e dei suoi indici derivati (PSA età-specifico, densità-PSAD, velocità-PSAV, PSA libero-f-PSA) nella diagnosi del carcinoma della prostata] 29
Correlation between serum PSA and intraprostatic concentration of EGF and DHT in patients with BPH 29
Is medical therapy an expensive way for delaying surgery in BPH patients? 28
Correlazione fra i livelli dell'antigene specifico prostatico e i livelli intratissutali del diidrotestosterone ed epidermal growth factor in pazienti con ipertrofia prostatica benigna 28
Adenocarcinoma renale in rene policistico congenito dell’adulto. Short case: problema oncologico. 28
Risk-factors in renal cell carcinoma (RCC). 28
Correlation between epidermal growth factor and steroid receptors in benign prostatic hypertrophy 27
Plant extracts in BPH 27
Zonal distribution of androgens and epidermal growth factor (EGF) in human BPH tissue: responsiveness to flutamide, finasteride and serenoa repens administration 27
Influenza della ploidia del DNA, dei livelli di PSA e del Gleason score nella sopravvivenza libera da malattia dopo chirurgia radicale per carcinoma della prostata 26
Vie di accesso ecografiche nei tumori vescicali 26
Tumore del testicolo a cellule germinali "Burned out". 26
Analisi multivariata dei fattori prognostici del carcinoma renale 26
Right nephrectomy of renal cell carcinoma and excision of omolateral pulmonary metastasis. 26
Esperienza con Flutamide nel trattamento di seconda linea. 26
Valutazione dei margini chirurgici in pazienti affetti da adenocarcinoma prostatico clinicamente intracapsulare 26
Response of tissue androgen and epidermal growth factor concentrations to the administration of Finasteride,Flutamide and Serenoa Repens in patients with BPH. 25
Oncological and functional management in nerve sparing radical prostatectomy: periprostatic neurovascular bundles (NVB) evaluation with magnetic resonance imaging (MRI) and prostate mapping with spectroscopy. 25
Biological significance and prognostic implications of cellular DNA content in human renal cell carcinomas. 25
Nefrectomia destra con asportazione contemporanea di metastasi polmonare unica per tumore del rene 25
IPERTROFIA PROSTATICA BENIGNA.ASPETTI ISTOPATOLOGICI ED INQUADRAMENTO CLINICO 24
Clinical and hormonal response to flutamide treatment after orchiectomy plus cyproterone acetate in patients with prostatic carcinoma 24
Tumore del testicolo a cellule germinali "Burned out". 24
Treatment with orgotein of induratio penis plastica 24
Is there always a role for radical prostatectomy in the treatment of localized prostate cancer? 23
The role of growth factors and androgen receptors in benign prostatic hyperplasia 23
Renal cell carcinoma (RCC) associated with primary tumors involving different steroid hormone target tissues: Relationship with reproductive and hormone factors 23
Evaluation of causes of obstructive uropathy by pyelography. 23
Influenza degli isoflavonidi ed altri componenti della dieta alimentare nello sviluppo del carcinoma prostatico. 23
Incidental prostate carcinoma: 4-year follow up following treatment with cyproterone acetate 23
Totale 4.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020677 0 0 0 0 53 143 173 99 66 76 51 16
2020/2021341 32 25 13 70 15 21 10 46 21 51 25 12
2021/20221.807 11 122 137 68 269 18 40 154 128 185 219 456
2022/20231.562 463 290 49 149 144 168 27 66 125 16 45 20
2023/2024680 62 73 14 34 25 27 51 28 7 133 76 150
2024/2025317 71 63 80 49 54 0 0 0 0 0 0 0
Totale 6.624